Events

Water Cooler Chat: Running Clinical Trials in Israel & Growing Beyond

Wednesday October 28th at 1pm BST/3pm IDT/9am EST

Commencing phase I trials in Israel can be started with short notice, as no licenses are needed.

Phase II and III trials in Israel and globally require more planning and a longer timeline. Trial sponsors need to:

  • Identify an appropriate clinical trial services provider
  • Work with GMP regulations
  • Understand regulatory and distribution timelines

Trial sponsors adding Israel as a phase II selection need to be aware of Israel’s requirements such as:

  • The considerations of shipping from your clinical trial services provider into Israel
  • Requirements for recertification
  • Israeli QP requirements
  • Returns and reconciliations

On October 28, 1pm BST/3pm IDT/9am EST, join PCI and our guests as we discuss the significant jump from phase I to phase II trials in Israel and the clinical supply chain considerations of choosing Israel as a phase II trial location.

Speakers:

  • Moderator: Dan Millard, Business Development Manager, PCI Clinical Trial Services
  • Gavin Morgan, Sr. Manager, Global Logistics, PCI Clinical Trial Services
  • Paula Strauss-Levy, PCI Clinical Trial Services
  • Amir Malka, IMP – Clinical Supply Services

To register for this event, please click here:

Event details

Wednesday October 28th at 1pm BST/3pm IDT/9am EST

Water Cooler Chat Virtual Series

When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?

Your bridge between life-changing therapies and patients